The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. S.
Right arrow Articles by Madsen, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. S.
Right arrow Articles by Madsen, J. C.
The Journal of Immunology, 2000, 164: 3434-3444.
Copyright © 2000 by The American Association of Immunologists

Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses1

Richard S. Lee2, Kazuhiko Yamada2, Karl L. Womer3, Edmund P. Pillsbury2, Kenneth S. Allison2, Ariane E. Marolewski4, Dong Geng4, Aron D. Thall5, J. Scott Arn2, David H. Sachs2, Mohamed H. Sayegh3 and Joren C. Madsen6,7

Division of Cardiac Surgery and the Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital, Laboratory of Immunogenetics and Transplantation, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02114

Despite increasing use of swine in transplantation research, the ability to block costimulation of allogeneic T cell responses has not been demonstrated in swine, and the effects of costimulatory blockade on xenogeneic human anti-porcine T cell responses are also not clear. We have compared the in vitro effects of anti-human CD154 mAb and human CTLA4IgG4 on allogeneic pig T cell responses and xenogeneic human anti-pig T cell responses. Both anti-CD154 mAb and CTLA4IgG4 cross-reacted on pig cells. While anti-CD154 mAb and CTLA4IgG4 both inhibited the primary allogeneic pig MLRs, CTLA4IgG4 (7.88 µg/ml) was considerably more inhibitory than anti-CD154 mAb (100 µg/ml) at optimal doses. Anti-CD154 mAb inhibited the production of IFN-{gamma} by 75%, but did not inhibit IL-10 production, while CTLA4IgG4 completely inhibited the production of both IFN-{gamma} and IL-10. In secondary allogeneic pig MLRs, CTLA4IgG4, but not anti-CD154 mAb, induced Ag-specific T cell anergy. CTLAIgG4 completely blocked the indirect pathway of allorecognition, while anti-CD154 mAb blocked the indirect response by approximately 50%. The generation of porcine CTLs was inhibited by CTLA4IgG4, but not by anti-CD154 mAb. Human anti-porcine xenogeneic MLRs were blocked by CTLA4IgG4, but only minimally by anti-CD154 mAb. Finally, CTLA4IgG4 prevented secondary xenogeneic human anti-porcine T cell responses. These data indicate that blockade of the B7-CD28 pathway was more effective than blockade of the CD40-CD154 pathway in inhibiting allogeneic pig T cell responses and xenogeneic human anti-pig T cell responses in vitro. These findings have implications for inhibiting cell-mediated immune responses in pig-to-human xenotransplantation.




This article has been cited by other articles:


Home page
DiabetesHome page
V. Mirenda, D. Golshayan, J. Read, I. Berton, A. N. Warrens, A. Dorling, and R. I. Lechler
Achieving Permanent Survival of Islet Xenografts by Independent Manipulation of Direct and Indirect T-Cell Responses
Diabetes, April 1, 2005; 54(4): 1048 - 1055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Costa, D. F. Barber, and W. L. Fodor
Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells
J. Immunol., April 15, 2002; 168(8): 3808 - 3816.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. S. Lee, K. Yamada, S. L. Houser, K. L. Womer, M. E. Maloney, H. S. Rose, M. H. Sayegh, and J. C. Madsen
Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy
PNAS, March 13, 2001; 98(6): 3276 - 3281.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. S. Lee, J. R. Rusche, M. E. Maloney, D. H. Sachs, M. H. Sayegh, and J. C. Madsen
CTLA4Ig-Induced Linked Regulation of Allogeneic T Cell Responses
J. Immunol., February 1, 2001; 166(3): 1572 - 1582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.